The latest edition of Australian
Prescriber includes an update on
medicines for smoking cessation.
As well as nicotine replacement
therapy, the respective roles of
varenicline (Champix from Pfizer),
bupropion (Zyban from Aspen,
or Prexaton from Ascent) and
e-cigarettes are discussed.
“While there is some evidence
that electronic cigarettes might
facilitate smoking cessation, quit
rates are not yet comparable with
those of the drugs approved on the
Pharmaceutical Benefits Scheme,”
said the authors.The above article was sent to subscribers in Pharmacy Daily's issue from 04 Aug 15 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 04 Aug 15
DEMENTIA Australia has appointed comedian Geraldine Hickey (pictured) as its newest Ambassador, coinciding with the Melbourne Memory Walk & Jog event taking place this Sun.
NEW research from the Monash Addiction Research Centre has highlighted a critical shortfall in the availability of Naloxone, a life-saving medication that reverses opioid overdoses, across community pharmacies in Australia’s most populous states.
THE Senate’s Community Affairs Legislation Committee is holding a two-day inquiry into the Therapeutic Goods and Other Legislation Amendment (Vaping Reforms) Bill 2024, which is currently under discussion in Federal Parliament.
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.